Science Explorer Back to mapMap
Discussion
Hospital / health system · Chiba · Japan

Chiba Cancer Center

In research, Chiba Cancer Center stands highest in Health Sciences (#3,304 of 9,902 worldwide) and Medicine (#3,201 of 8,541 worldwide), 2022-now. Relative to its size it is most specialised in Oncology, Pulmonary and Respiratory Medicine and Surgery (Oncology is 15.4× its share of world research).

pref.chiba.lg.jp/ganROR OpenAlex
World rank, 2022-now
#14,098
of 22,385 · #16,819 all time
Rank in Japan
#399
of 924
Research works
1.7k
▼ 25% vs 2018-21
Citations
33k
19.6 per fractional work
Top-10% rate
7.7%
all institutions 10.0%
vs its own fields
0.93×
1.00× is exactly expected
Open access
41%
world 40%
International
9%
world 18%
Chiba Cancer Center

What is Chiba Cancer Center known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #3,304 of 9,902 7.1%130 #5738
MedicineField #3,201 of 8,541 7.3%127 #5258

Each strip is that field's whole ranked pool, with the notch where Chiba Cancer Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Chiba Cancer Center work in?

In 2022-now, 72% of research at Chiba Cancer Center is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (71%), Biochemistry, Genetics and Molecular Biology (17%), Immunology and Microbiology (5%). It does 3.0× the world's share of Health Sciences.

Health Sciences: 145 fractional works · 72.2% of its workMedicine: 142 fractional works · 70.7% of its workOncology: 35 fractional works · 17.3% of its workPulmonary and Respiratory Medicine: 30 fractional works · 14.7% of its workSurgery: 29 fractional works · 14.2% of its workEpidemiology: 7 fractional works · 3.4% of its workPathology and Forensic Medicine: 4 fractional works · 2.1% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 2.1% of its workNeurology: 4 fractional works · 1.9% of its workObstetrics and Gynecology: 3 fractional works · 1.6% of its workGastroenterology: 3 fractional works · 1.3% of its workGenetics: 2 fractional works · 1.2% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 1.1% of its workPhysiology: 2 fractional works · 1.1% of its workRheumatology: 2 fractional works · 1.1% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 1.0% of its workOtorhinolaryngology: 2 fractional works · 0.8% of its workHematology: 1 fractional works · 0.7% of its workHepatology: 1 fractional works · 0.6% of its workDermatology: 1 fractional works · 0.6% of its workGeriatrics and Gerontology: 1 fractional works · 0.5% of its workPsychiatry and Mental health: 1 fractional works · 0.5% of its workInfectious Diseases: 1 fractional works · 0.4% of its workCritical Care and Intensive Care Medicine: 1 fractional works · 0.3% of its workInternal Medicine: 1 fractional works · 0.3% of its workAnesthesiology and Pain Medicine: 1 fractional works · 0.3% of its workImmunology and Allergy: 0 fractional works · 0.2% of its workReproductive Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 1.2% of its workHealth Professions: 2 fractional works · 0.8% of its workGeneral Health Professions: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.6% of its workNursing: 1 fractional works · 0.4% of its workNutrition and Dietetics: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workDentistry: 0 fractional works · 0.2% of its workOral Surgery: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.1% of its workLife Sciences: 48 fractional works · 23.8% of its workBiochemistry, Genetics and Molecular Biology: 35 fractional works · 17.5% of its workMolecular Biology: 20 fractional works · 10.1% of its workCancer Research: 10 fractional works · 4.9% of its workGenetics: 2 fractional works · 1.2% of its workCell Biology: 1 fractional works · 0.5% of its workMolecular Medicine: 0 fractional works · 0.2% of its workBiotechnology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 10 fractional works · 4.9% of its workImmunology: 9 fractional works · 4.5% of its workSmaller subfields together: 1 fractional works · 0.4% of its workNeuroscience: 1 fractional works · 0.7% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.5% of its workAgricultural and Biological Sciences: 1 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.3% of its workPharmacology: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPhysical Sciences: 6 fractional works · 3.1% of its workEngineering: 2 fractional works · 1.1% of its workBiomedical Engineering: 2 fractional works · 0.9% of its workSmaller subfields together: 1 fractional works · 0.3% of its workPhysics and Astronomy: 2 fractional works · 0.8% of its workRadiation: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 1 fractional works · 0.5% of its workOrganic Chemistry: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 1 fractional works · 0.3% of its workComputer Science: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.1% of its workEarth and Planetary Sciences: 0 fractional works · 0.0% of its workSocial Sciences: 2 fractional works · 0.8% of its workSocial Sciences: 1 fractional works · 0.5% of its workHealth: 0 fractional works · 0.2% of its workSociology and Political Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPsychology: 1 fractional works · 0.3% of its workClinical Psychology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.0% of its workALL ITS WORKChiba CancerCenter201fractional works, 2022-now
Life Sciences24%Physical Sciences3%Health Sciences72%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Medicine14270.7%
    2. Health Professions20.8%
    3. Nursing10.4%
    4. Dentistry00.2%
    5. Veterinary00.1%
    1. Biochemistry, Genetics and Molecular Biology3517.5%
    2. Immunology and Microbiology104.9%
    3. Neuroscience10.7%
    4. Agricultural and Biological Sciences10.4%
    5. Pharmacology, Toxicology and Pharmaceutics10.3%
    1. Engineering21.1%
    2. Physics and Astronomy20.8%
    3. Chemistry10.5%
    4. Environmental Science10.3%
    5. Computer Science00.1%
    6. Materials Science00.1%
    7. Earth and Planetary Sciences00.0%
    8. Mathematics00.0%
    1. Social Sciences10.5%
    2. Psychology10.3%
    3. Economics, Econometrics and Finance00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Chiba Cancer Center specialise in?

Where its research is concentrated relative to its size: Oncology takes 15.4× the share of its output that it takes of world research.

  1. OncologySubfield · 34.8 works15×
  2. Pulmonary and Respiratory MedicineSubfield · 29.5 works9.6×
  3. SurgerySubfield · 28.5 works6.1×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.28× its world share, 35 worksBiochemistry, Geneti…Immunology and Microbiology: 4.86× its world share, 10 worksImmunology and Micro…Neuroscience: 0.43× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.84× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.34× its world share, 1 worksChemistryComputer Science: 0.02× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.03× its world share, 0 worksEarth and Planetary …Engineering: 0.08× its world share, 2 worksEngineeringEnvironmental Science: 0.06× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.04× its world share, 0 worksMaterials ScienceMathematics: 0.01× its world share, 0 worksMathematicsPhysics and Astronomy: 0.36× its world share, 2 worksPhysics and AstronomyDentistry: 0.47× its world share, 0 worksDentistryHealth Professions: 0.32× its world share, 2 worksHealth ProfessionsMedicine: 3.68× its world share, 142 worksMedicineNursing: 0.75× its world share, 1 worksNursingVeterinary: 0.66× its world share, 0 worksVeterinaryEconomics, Econometrics and Finance: 0.02× its world share, 0 worksEconomics, Econometr…Psychology: 0.11× its world share, 1 worksPsychologySocial Sciences: 0.04× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.9×. Every wedge is a field page.

All 21 fields, with their numbers
  1. Immunology and Microbiology4.86×10 works
  2. Medicine3.68×142 works
  3. Biochemistry, Genetics and Molecular Biology3.28×35 works
  4. Pharmacology, Toxicology and Pharmaceutics0.84×1 works
  5. Nursing0.75×1 works
  6. Veterinary0.66×0 works
  7. Dentistry0.47×0 works
  8. Neuroscience0.43×1 works
  9. Physics and Astronomy0.36×2 works
  10. Chemistry0.34×1 works
  11. Health Professions0.32×2 works
  12. Psychology0.11×1 works
  13. Agricultural and Biological Sciences0.09×1 works
  14. Engineering0.08×2 works
  15. Environmental Science0.06×1 works
  16. Materials Science0.04×0 works
  17. Social Sciences0.04×1 works
  18. Earth and Planetary Sciences0.03×0 works
  19. Computer Science0.02×0 works
  20. Economics, Econometrics and Finance0.02×0 works
  21. Mathematics0.01×0 works

Who are the top researchers at Chiba Cancer Center?

Ranked on the quality score, Keiko Minashi, Akira Nakagawara and Miki Ohira lead among researchers whose main affiliation is Chiba Cancer Center.

  1. 1 Keiko Minashi Japan · #541,487 worldwide 9k citations · 237 works
  2. 2 Akira Nakagawara Japan · #797,326 worldwide 24k citations · 526 works
  3. 3 Miki Ohira Japan · #864,718 worldwide 8.3k citations · 310 works
  4. 4 Kiyohiro Ando Japan · #1,067,802 worldwide 4k citations · 84 works
  5. 5 Meiji Itakura Japan · #1,151,427 worldwide 1.4k citations · 34 works
  6. 6 Yusuke Amanuma Japan · #1,322,744 worldwide 2.2k citations · 73 works
  7. 7 Shintaro Iwata Japan · #1,467,746 worldwide 3.2k citations · 232 works
  8. 8 Tadamichi Denda Japan · #1,477,928 worldwide 3.5k citations · 280 works
  9. 9 Hiroki Nagase Japan · #1,894,795 worldwide 9.6k citations · 279 works
  10. 10 Satoshi Fukasawa Japan · #2,017,713 worldwide 3.5k citations · 107 works
All ranked researchers at Chiba Cancer Center

What are the most cited papers from Chiba Cancer Center?

The most cited paper from Chiba Cancer Center is "Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma" (Robert John Motzer et al., 2015), with 5,972 citations. Next come "Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial" (2,505) and "Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial" (2,317).

Most cited papers
#PaperReleasedCitations
1 Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma Robert John Motzer et al. · New England Journal of Medicine Open access 25 Sep 2015 5,972
2 Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial Hansjochen Wilke, Kei Muro, Eric Van Cutsem et al. · The Lancet Oncology 17 Sep 2014 2,505
3 Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial Yoon‐Koo Kang et al. · The Lancet Open access 12 Oct 2017 2,317
4 Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases Hidefumi Aoyama, Hiroki Shirato, Masao Tago et al. · JAMA 6 Jun 2006 2,226
5 ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis Kaori Ishikawa, Keizo Takenaga, Miho Akimoto et al. · Science Open access 3 Apr 2008 1,483
All 60 most cited papers, with filters and sorting

Which keywords describe research at Chiba Cancer Center?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Immunotherapy, Prognostic Factors, Tumor Microenvironment, Neoadjuvant Therapy, Survival Analysis and Radiotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy30▲ 21×21 topics
  2. Clinical Practice Guidelines20▲ 18×13 topics
  3. Epidemiology18▲ 2.2×48 topics
  4. Immunotherapy17▲ 11×16 topics
  5. Prognostic Factors16▲ 18×12 topics
  6. Tumor Microenvironment14▲ 15×7 topics
  7. Neoadjuvant Therapy14▲ 28×5 topics
  8. Cancer13▲ 4.9×35 topics
  9. Survival Analysis12▲ 21×6 topics
  10. Radiotherapy12▲ 15×11 topics
  11. Inflammation11▲ 2.6×39 topics
  12. Targeted Therapy10▲ 23×4 topics
  13. Endoscopic Resection10▲ 50×2 topics
  14. Clinical Trials8▲ 5.7×9 topics
  15. Quality of Life8▲ 2.6×16 topics
  16. Gene Expression7▲ 5.9×12 topics
  17. Adjuvant Therapy7▲ 28×2 topics
  18. Complications7▲ 7.1×10 topics
  19. Preoperative Chemoradiotherapy7▲ 44×2 topics
  20. Gastric Cancer7▲ 31×3 topics
  21. Surgical Management7▲ 8.3×13 topics
  22. Molecular Characterization7▲ 19×5 topics
  23. Chemoradiation6▲ 46×2 topics
  24. Immune Checkpoint Blockade6▲ 26×1 topic
  25. PD-1 and PD-L16▲ 26×1 topic
  26. Surgery6▲ 8.5×6 topics
  27. Genetic Mutations6▲ 6.7×13 topics
  28. Metastasis6▲ 8.2×10 topics
  29. Osteosarcoma6▲ 61×1 topic
  30. Soft Tissue Sarcoma6▲ 54×1 topic
  31. Breast Cancer6▲ 11×10 topics
  32. Molecular Subtypes5▲ 31×3 topics
  33. Neoadjuvant Chemotherapy5▲ 32×2 topics
  34. Lymph Node Dissection5▲ 46×1 topic
  35. Metastatic Gastric Cancer5▲ 46×1 topic
  36. Tumor Markers5▲ 30×2 topics
  37. Barrett's Esophagus5▲ 57×1 topic
  38. Esophageal Carcinoma5▲ 57×1 topic
  39. Molecular Classification5▲ 15×4 topics
  40. Cancer Immunotherapy4▲ 14×3 topics

Which research topics does Chiba Cancer Center publish most on?

By volume in 2022-now: Cancer Immunotherapy and Biomarkers, Sarcoma Diagnosis and Treatment, Gastric Cancer Management and Outcomes and Esophageal Cancer Research and Treatment.

Cancer Immunotherapy and…6Cancer Immunotherapy and Biomarkers: 6 fractional worksSarcoma Diagnosis and Tr…6Sarcoma Diagnosis and Treatment: 6 fractional worksGastric Cancer Managemen…5Gastric Cancer Management and Outcomes: 5 fractional worksEsophageal Cancer Resear…5Esophageal Cancer Research and Treatment: 5 fractional worksPancreatic and Hepatic Oncology Research: 4 fractional worksCancer Genomics and Diagnostics: 4 fractional worksLung Cancer Treatments a…4Lung Cancer Treatments and Mutations: 4 fractional worksColorectal Cancer Treatments and Studies: 3 fractional worksLung Cancer Research Studies: 3 fractional worksBreast Cancer Treatment Studies: 2 fractional works
OncologyPulmonary and Respiratory MedicineSurgeryCancer Research

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 6 works
  2. 2 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 6 works
  3. 3 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 5 works
  4. 4 Esophageal Cancer Research and Treatment Surgery 5 works
  5. 5 Pancreatic and Hepatic Oncology Research Oncology 4 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 4 works
  7. 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
  8. 8 Colorectal Cancer Treatments and Studies Oncology 3 works
  9. 9 Lung Cancer Research Studies Oncology 3 works
  10. 10 Breast Cancer Treatment Studies Cancer Research 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.8%not open59.2%

World: 40% of research is openly available.

with international co-authors9.0%domestic only91.0%

World: 18% is written across borders.

How has Chiba Cancer Center's research output changed?

Output in 2022-2025 was 25% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Chiba Cancer Center as a percentage of every work published that year, 0.00081% in 2024.

still counting0.0020%0.0040%0.0060%Chiba Cancer Center0.00080% in 202519801990200020102020

Fractional works of Chiba Cancer Center over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%all institutions10.0% in 2025Chiba Cancer Center8.7% in 2025200020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 15.1% in 2014.

Other research institutions in Chiba

All research institutions in Chiba

Share Chiba Cancer Center's ranking

Chiba Cancer Center on Science Explorer

A card with Chiba Cancer Center's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Chiba Cancer Center. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.